<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[advisory committee Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/advisory+committee.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to advisory committee]]></description>
	<s:counts start="0" returned="20" found="244" />
	<language>en-us</language>
	<item>
		<title><![CDATA[XenoPort, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-328784.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator instructions Your first question comes from the line of Eric Schmidt of Cowen and Company.  Eric Schmidt &#8211; Cowen and Company  Good afternoon. Thanks for taking my questions. Ron, has the FDA received the open-label expansion data for 512?  Ron Barrett ...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 05 Aug 2009 19:22:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[Advisory Committee]]></category>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/xenoport+inc..html"><![CDATA[XenoPort Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XNPT</category>
		<category domain="tickers">XNPT</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-300216.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions We will go to Eric Schmidt with Cowen & Company. Eric Schmidt &#8211; Cowen & Company Well thanks for taking my call. Just on the prelaunch activities, when would you estimate, something you've got to favorable recommendation of the panel and approval on August 1,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 08 May 2009 05:48:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[Advisory Committee]]></category>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m4PRN/is_2008_May_7/ai_n25398472]]></link>
		<description><![CDATA[WOODCLIFF LAKE, N.J., May 7  /PRNewswire/ -- Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration FDA Advisory Committee on Anesthetic and Life Support Drugs ALSDAC has voted 6 to 3 in favor with one abstention of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze&#153; for Hereditary Angioedema]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_2/ai_n25378153]]></link>
		<description><![CDATA[Company to Host Conference Call on Monday, May 5 at 8:30 am EST]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ANA advocates for critical RN representation on the U.S. Department of Health and Human Services Secretary's Advisory Committee on National Health Promotion and Disease Prevention]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m5QJU/is_2_11/ai_n25353939]]></link>
		<description><![CDATA[SILVER SPRINGS, MD--In advance of a series of regional hearings being convened by the U.S. Department of Health and Human Services HHS to discuss the objectives for "Healthy People 2020," the American Nurses Association ANA is calling for representation of the nursing profession and nursing community on the HHS Secretary's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+health+and+human+services.html"><![CDATA[U.S. Department of Health and Human Services]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Advanced Cell Technology's Executive Invited to Present Today to FDA Advisory Committee on Cellular Tissue Therapies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_10/ai_n25147434]]></link>
		<description><![CDATA[ALAMEDA, Calif. -- Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that Jonathan H. Dinsmore Ph.D., Senior Vice President - Regulatory and Clinical, has been invited to present to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research Advisory Committee on Cellular, Tissue and Gene Therapies. Dr....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 10 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Assessing the CIFiR committee's run at complexity.(washington insights)(Advisory Committee on Improvements to Financial Reporting)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6626/is_200804/ai_n26471858]]></link>
		<description><![CDATA[Once again, it's time to take a good look at Washington  efforts surrounding the complexity crisis in financial reporting. In a  column last October, this writer examined the highly lauded formation of  the U.S. Securities and Exchange Commission's (SEC  Once again, it's time to take a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/financial+reporting.html"><![CDATA[financial reporting]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze &#153;]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_13/ai_n24920732]]></link>
		<description><![CDATA[NEW YORK -- Lev Pharmaceuticals, Inc. (OTCBB: LEVP.OB) today announced that it has been advised that the Blood Products Advisory Committee BPAC for U.S. Food and Drug Administration FDA intends to review the Biologics License Application BLA for Cinryze (C1 inhibitor) on May 2, 2008, for the prophylactic treatment of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FDAAdvisoryCommittee.com Will Webcast the March 13th FDA Oncologic Drugs Advisory Committee (ODAC) Meeting, Powered by TalkPoint Technology]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200803/ai_n24390934]]></link>
		<description><![CDATA[TalkPoint, leading provider of the Tools, Technology and Services for Interactive  Internet Broadcasting  and FDAAdvisoryCommittee.com, the premiere live  webcast  and archive DVD library for FDA Advisory Committee Meetings, announced that TalkPoint will be powering the March 13th FDAAdvisoryCommittee.com webcast of the Oncologic Drugs Advisory Committee Meeting. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 11 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Theravance Receives Additional Information Regarding FDA Cancellation of Advisory Committee Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200803/ai_n24367404]]></link>
		<description><![CDATA[Theravance, Inc. (NASDAQ: THRX) announced today that it has been informed by the U.S. Food and Drug Administration FDA that the February 27th planned review of telavancin by the Anti-Infective Drugs Advisory Committee AIDAC was cancelled on February 23rd in order to allow time for the FDA to further evaluate...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Mar 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Rotarix® Receives Favorable Recommendation from FDA Advisory Committee]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Feb_21/ai_n24318612]]></link>
		<description><![CDATA[NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Rotarix([R]), an oral, two-dose rotavirus candidate vaccine to prevent rotavirus gastroenteritis in infants, received a favorable recommendation from the U.S. Food and Drug Administration's FDA Vaccines and Related Biological Products Advisory Committee VRBPAC. AVANT licensed the technology for Rotarix([R])...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 21 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FDA published today that it will not hold an advisory committee meeting on ceftobiprole in the treatment of complicated skin and skin structure infections]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200802/ai_n21413907]]></link>
		<description><![CDATA[Basilea Pharmaceutica (SWX: BSLN) announces that the US Food and Drug Administration FDA determined that the Anti-Infective Drugs Advisory Committee meeting scheduled for February 28, 2008 will not be held, as provided for under the provisions of the amendment of Section 505 of the Federal Food, Drug, and Cosmetic Act. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Feb 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Advisory Committee Process Changes]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5979/is_200801/ai_n24154744]]></link>
		<description><![CDATA[The Food and Drug Administration FDA announced on November 15 steps to strengthen its advisory committee processes in response to recent recommendations from the Institute of Medicine. The measures include proposed new guidance or procedures on advisoryThe Food and Drug Administration FDA announced on November 15 steps to strengthen its...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200712/ai_n21800294]]></link>
		<description><![CDATA[To: NATIONAL EDITORSTo: NATIONAL EDITORS]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 14 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Adolor and GlaxoSmithKline Announce FDA Advisory Committee to Review Entereg®  for the Management of Postoperative Ileus]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_28/ai_n27469296]]></link>
		<description><![CDATA[EXTON, Pa. & PHILADELPHIA -- Adolor Corporation (Nasdaq:ADLR) and GlaxoSmithKline (NYSE:GSK) announced today that the Gastrointestinal Drugs Advisory Committee to the U.S. Food and Drug Administration FDA will review Adolor's New Drug Application NDA for Entereg[R] alvimopan for the proposed indication of acceleration of time to upper and lower gastrointestinal...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[U.S. Labor Secretary Elaine L. Chao Announces New Membership of OSHA Advisory Committee]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200711/ai_n21796998]]></link>
		<description><![CDATA[To: NATIONAL EDITORSTo: NATIONAL EDITORS]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 15 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/osha.html"><![CDATA[OSHA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[OSHA Schedules Maritime Advisory Committee Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200711/ai_n21795946]]></link>
		<description><![CDATA[To: NATIONAL EDITORSTo: NATIONAL EDITORS]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 07 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/osha.html"><![CDATA[OSHA]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CEA Forms International Advisory Committee]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_5/ai_n21081717]]></link>
		<description><![CDATA[Committee to Provide Counsel on International Issues Related to the Consumer Electronics Industry]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 05 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+electronics+association.html"><![CDATA[Consumer Electronics Association]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FiSCA Appears Before FDIC Advisory Committee on Economic Inclusion - Calls for Partnership to Improve Service to Low and Moderate Income Consumers]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200710/ai_n21917754]]></link>
		<description><![CDATA[To: BUSINESS EDITORSTo: BUSINESS EDITORS]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fdic.html"><![CDATA[FDIC]]></category>
		<category domain="http://resources.bnet.com/topic/income.html"><![CDATA[income]]></category>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[partnership]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5570/is_200710/ai_n23660648]]></link>
		<description><![CDATA[PHILADELPHIA, October 17 /PRNewswire/ --    PHILADELPHIA, October 17 /PRNewswire/ --  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 16 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[advisory committee]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
